Development of α-Helical Antimicrobial Peptides with Imperfect Amphipathicity for Superior Activity and Selectivity
Journal of Medicinal Chemistry · 14.11.2024 · 67 (21) · 19561-19572
DOI: 10.1021/acs.jmedchem.4c01855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 01.11.2024. Verfasst von Zhongxiang Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan 650031, China. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, Anti-Bacterial Agents, Antimicrobial Peptides, Protein Conformation, alpha-Helical. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Yunnan province.
Abstract (Originalsprache)
The advancement of antimicrobial peptides (AMPs) as therapeutic agents is hindered by their poor selectivity. Recent evidence indicates that controlled disruption of the amphipathicity of α-helical AMPs may increase the selectivity. This study investigated the role of imperfect amphipathicity in optimizing AMPs with varied sequences to enhance their activity and selectivity. Among these, the lead peptide RI-18, characterized by an imperfectly amphipathic α-helical structure, demonstrated potent and broad-spectrum antibacterial activity without inducing hemolytic or cytotoxic effects. RI-18 effectively eliminated planktonic and biofilm-associated bacteria as well as persister cells and exhibited high bacterial plasma membrane affinity, inducing rapid membrane permeabilization and rupture. Notably, RI-18 significantly reduced bacterial loads without promoting bacterial resistance, highlighting its therapeutic potential. Overall, this study identified RI-18 as a promising antimicrobial candidate. The rational strategy of tuning imperfect amphipathicity to enhance the AMP activity and selectivity may facilitate the design and development of AMPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan 650031, China.
- State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.
- School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan 650500, China.
- School of Life Sciences, Yunnan University, Kunming 650500, China.
- Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, Sichuan 610041, China.
ORCID-Profile: Gan Wang, Zhiye Zhang
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Yunnan province
Zitieren
APA
Wu, Z., Cai, Y., Han, Y., Su, Y., Zhang, T., Wang, X., Yan, A., Wang, L., Wu, S., Wang, G., & Zhang, Z. (2024). Development of α-Helical Antimicrobial Peptides with Imperfect Amphipathicity for Superior Activity and Selectivity. Journal of Medicinal Chemistry, 67(21), 19561-19572. https://doi.org/10.1021/acs.jmedchem.4c01855
Vancouver
Wu Z, Cai Y, Han Y, Su Y, Zhang T, Wang X, et al. Development of α-Helical Antimicrobial Peptides with Imperfect Amphipathicity for Superior Activity and Selectivity. Journal of Medicinal Chemistry. 2024;67(21):19561-19572. doi:10.1021/acs.jmedchem.4c01855
BibTeX
@article{Wu2024,
author = {Wu, Zhongxiang and Cai, Ying and Han, Yajun and Su, Yunhan and Zhang, Tianyu and Wang, Xingyu and Yan, An and Wang, Liunan and Wu, Sijing and Wang, Gan and Zhang, Zhiye},
title = {Development of α-Helical Antimicrobial Peptides with Imperfect Amphipathicity for Superior Activity and Selectivity},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {21},
pages = {19561--19572},
doi = {10.1021/acs.jmedchem.4c01855}
}
EUVIMED